Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

Chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barré syndrome (GBS) are immune-mediated neuropathies. Their pathogenesis involves an immune response to non-protein antigens, ...

The Guillain-Barre Syndrome (GBS) outbreak in Pune has subsided considerably, health officials said on Wednesday, adding that there were no new hospital admissions linked to the rare neurological ...

In lieu of flowers, please consider a donation to the GBS/CIDP Foundation International or to Penn State St. Joseph Medical Center. Online condolences can be made at maestumpfuneralhome.com ...

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...

If you’re looking for a cannabidiol (CBD) product to soothe your aches and pains, a topical CBD — such as a CBD cream — may be particularly useful. But how can you tell which CBD creams are ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Maharashtra has witnessed 224 cases of Guillain-Barre-Syndrome (GBS) and 12 deaths due to it till March 3, Minister of State for Health Prataprao Jadhav told the Rajya Sabha on Tuesday. The ...

Guillain-Barré syndrome (GBS) is a rare immune-mediated disorder of the peripheral nerves. Although its cause is not fully understood, the syndrome often follows infection with a virus or bacteria, ...